TANA, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 2.175
EU - Europa 1.410
AS - Asia 1.358
SA - Sud America 177
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 6
Totale 5.146
Nazione #
US - Stati Uniti d'America 2.121
SG - Singapore 607
CN - Cina 406
IT - Italia 253
IE - Irlanda 238
SE - Svezia 217
BR - Brasile 154
UA - Ucraina 147
GB - Regno Unito 137
DE - Germania 131
TR - Turchia 118
VN - Vietnam 96
FR - Francia 95
IN - India 66
FI - Finlandia 54
RU - Federazione Russa 33
AT - Austria 29
CA - Canada 27
PL - Polonia 20
ES - Italia 16
MX - Messico 16
BD - Bangladesh 13
HK - Hong Kong 13
AR - Argentina 12
LT - Lituania 10
RO - Romania 8
ZA - Sudafrica 8
IQ - Iraq 7
CZ - Repubblica Ceca 6
IR - Iran 6
JP - Giappone 6
NL - Olanda 6
EG - Egitto 4
PK - Pakistan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CL - Cile 3
UZ - Uzbekistan 3
AL - Albania 2
BE - Belgio 2
CI - Costa d'Avorio 2
CO - Colombia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EC - Ecuador 2
EU - Europa 2
ID - Indonesia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KZ - Kazakistan 1
MA - Marocco 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SV - El Salvador 1
SZ - Regno dello Swaziland 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.146
Città #
Singapore 439
Chandler 252
Dublin 228
Jacksonville 209
Ashburn 174
Beijing 143
Dallas 117
Princeton 100
Dearborn 98
Southend 88
Izmir 79
Santa Clara 73
Los Angeles 70
Nanjing 63
The Dalles 63
Munich 47
Altamura 45
New York 41
Ann Arbor 34
Wilmington 34
Cambridge 29
Chieti 26
Hanoi 26
São Paulo 26
Ho Chi Minh City 24
Redondo Beach 23
Vienna 23
Seattle 22
Boardman 20
Buffalo 18
Nanchang 18
Tongling 18
Warsaw 17
Dong Ket 16
Pescara 15
Denver 14
Montreal 14
Washington 14
Brooklyn 12
Gothenburg 12
Hebei 12
Hong Kong 12
Kunming 12
Poplar 12
Hefei 11
Houston 11
Orem 11
Turku 11
Woodbridge 11
Helsinki 10
Rome 10
Shenyang 10
Toronto 10
Phoenix 9
Augusta 8
Chennai 8
Council Bluffs 8
Leawood 8
London 8
Rio Saliceto 8
Tianjin 8
Ankara 7
Grevenbroich 7
Johannesburg 7
Milan 7
Monmouth Junction 7
Nuremberg 7
San Mateo 7
Stockholm 7
Jinan 6
Lappeenranta 6
Manchester 6
Norwalk 6
Perugia 6
Tokyo 6
Amsterdam 5
Atlanta 5
Baghdad 5
Brasília 5
Brno 5
Hangzhou 5
Mexico City 5
Querétaro 5
San Francisco 5
Zhengzhou 5
Changchun 4
Charlotte 4
Fairfield 4
Falls Church 4
Fuzhou 4
Goiânia 4
Haiphong 4
Iglesias 4
Jiaxing 4
Palermo 4
Rio de Janeiro 4
San Jose 4
Thái Nguyên 4
Vilnius 4
Bisenti 3
Totale 3.193
Nome #
Impact of migraine on fibromyalgia symptoms 206
Co-occurrence of pain syndromes 143
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 141
Sarcoidosis: Old certainties and new perspectives [La sarcoidosi: Vecchie certezze e nuove prospettive] 128
Cardiovascular risk in non-alcoholic fatty liver disease: Mechanisms and therapeutic implications 127
Use of Contrast-enhanced ultrasound (CEUS) in systemic mastocytosis. Report of two cases 126
Acute acalculous cholecystitis and cardiovascular disease: a land of confusion 125
microRNA profiling in atherosclerosis, diabetes, and migraine 121
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? 121
Hepatic artery resistive index (HARI) and non-alcoholic fatty liver disease (NAFLD) fibrosis score in NAFLD patients: cut-off suggestive of non-alcoholic steatohepatitis (NASH) evolution 119
Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache 118
Extrapulmonary sarcoidosis: A chameleon disease at imaging 110
Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization. 110
Immunopathogenesis of sarcoidosis and risk of malignancy: a lost truth? 106
Hepatic artery resistive index as surrogate marker for fibrosis progression in NAFLD patients: A clinical perspective 105
Aliased Flow Signal Planimetry by Cardiovascular Magnetic Resonance Imaging for Grading Aortic Stenosis Severity: A Prospective Pilot Study 105
Sonographic assessment of a suspected biloma: a case report and review of the literature. 104
Multifactorial headache in patient with chorio-retinal tuberculosis granuloma 104
Challenges in the diagnosis and treatment of neurosarcoidosis 104
Teaching neuroimages: a dangerous complication of spontaneous intracranial hypotension 102
Clinical Features and Diagnosis of Cardiac Sarcoidosis 97
Athlete’s Heart: Diagnostic Challenges and Future Perspectives 95
Pitfalls of contrast-enhanced ultrasound (CEUS) in the diagnosis of splenic sarcoidosis 93
An unusual case of urine bag discoloration 93
Muscle pain sensitivity in hypertensive patients with and without chronic pain 92
Correlation between Migraine Severity and Cholesterol Levels 92
NSAIDs for symptomatic treatment of headache 92
Can ultrasound give valuable clues in the diagnosis of bile leakage? 91
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 89
Ultrasound imaging of abdominal sarcoidosis: State of the art 89
Risk factors and current management of venous thromboembolism in patients with primary immune thrombocytopenic purpura 89
Severe non-traumatic bleeding, the answer is not in the blood 88
Chest Imaging of Patients with Sarcoidosis and SARS-CoV-2 Infection. Current Evidence and Clinical Perspectives 88
Gallbladder infection by trematodes 87
Nonalcoholic fatty liver disease and cardiovascular disease phenotypes 87
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 84
CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification 81
Approach to COVID-19 in older adults and indications for improving the outcomes 81
Splenic sarcoidosis remains a diagnostic challenge. 80
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 80
Lp(a) and cardiovascular risk: Investigating the hidden side of the moon 79
Heterogeneous delayed enhancement of the liver after administration of ultrasound contrast agents: are we sure that it is a harmless phenomenon? 78
Emphysematous pancreatitis associated with penetrating duodenal ulcer 78
Pain thresholds in women with chronic pelvic pain 77
Management of hyperuricemia and gout in obese patients undergoing bariatric surgery 74
Authors’ Reply to Kindermann et al.’s Comment on: “Athlete’s Heart: Diagnostic Challenges and Future Perspectives” 72
Neoangiogenesis is reduced in chronic tendinopathies of type II diabetic patients 69
Sarcoidosis and COVID-19: At the Cross-Road between Immunopathology and Clinical Manifestation 68
Common Clinical and Molecular Pathways between Migraine and Sarcoidosis 67
Splenic involvement in sarcoidosis mimicking hypoechoic metastases in colon cancer 65
A highly-detailed anatomical study of left atrial auricle as revealed by in-vivo computed tomography 60
Effects of topical vs injection treatment of cervical myofascial trigger points on headache symptoms in migraine patients: a retrospective analysis 57
Management Issues of Sarcoidosis in the Time of Coronavirus Disease 2019 55
Clinical and Cardiovascular Magnetic Resonance Imaging Features of Cardiac Amyloidosis 54
Ultrasound assessment of SARS-CoV-2 pneumonia: a literature review for the primary care physician 52
18F-FDG PET-CT Imaging in Sarcoidosis Molecular Mechanisms and Applications 52
New Therapeutic Options for Migraine 44
Pain from Internal Organs and Headache: The Challenge of Comorbidity 43
Long COVID and especially headache syndromes 39
Thromboembolic and bleeding risk in cardiac amyloidosis 37
URO-RESIST: A Real-World Retrospective Study on Multidrug-Resistant Sepsis with Urinary Tract Infection, Clinical Predictors, Inflammatory Biomarkers, and Patient Outcomes 11
Totale 5.424
Categoria #
all - tutte 23.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 0 46 7 4 11 21 43 24
2021/2022282 4 6 7 57 24 6 4 11 31 16 38 78
2022/2023767 67 143 60 62 58 140 43 64 88 13 18 11
2023/2024446 24 10 37 17 53 126 104 33 1 14 1 26
2024/20251.124 55 240 209 18 31 57 26 39 124 75 123 127
2025/20261.218 204 66 237 299 294 118 0 0 0 0 0 0
Totale 5.424